BOSTON — Despite heated rhetoric over the cost of prescription drugs, pricing of today’s medicines is “messy and complicated,” the governor of Massachusetts said Monday, allowing that pharmaceutical companies have the right to try to recoup their investments.

Gov. Charlie Baker, asked whether drug companies are “getting away with murder” as President Trump has alleged, said “innovation is expensive,” particularly when “figuring out the human body.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy